| 000 | 01583 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515020018.0 | ||
| 264 | 0 | _c20060605 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0095-1137 | ||
| 024 | 7 |
_a10.1128/JCM.44.3.1059-1064.2006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeavis, Helen L | |
| 245 | 0 | 0 |
_aHigh-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium. _h[electronic resource] |
| 260 |
_bJournal of clinical microbiology _cMar 2006 |
||
| 300 |
_a1059-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 |
_aDNA Gyrase _xgenetics |
| 650 | 0 | 4 |
_aDNA Topoisomerase IV _xgenetics |
| 650 | 0 | 4 |
_aDNA, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance, Bacterial _xgenetics |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 | _aGenes, Bacterial |
| 650 | 0 | 4 | _aGenomic Islands |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 |
_aVirulence _xgenetics |
| 700 | 1 | _aWillems, Rob J L | |
| 700 | 1 | _aTop, Janetta | |
| 700 | 1 | _aBonten, Marc J M | |
| 773 | 0 |
_tJournal of clinical microbiology _gvol. 44 _gno. 3 _gp. 1059-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.44.3.1059-1064.2006 _zAvailable from publisher's website |
| 999 |
_c16127815 _d16127815 |
||